Molecular pharmacology of GPCRs

Research output: Contribution to journalEditorialOther

Abstract

This themed section of the British Journal of Pharmacology stems from the ninth in the series of MPGPCR meetings, held as a joint initiative with the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists in Melbourne, Australia, from 28 to 30 November 2016. The articles provide insights into how GPCR environment can influence function, the identification of new drug targets based on allostery, biased agonism and oligomerization and the importance of taking into account sexual dimorphism in developing animal models for the evaluation of potential treatments for cardiovascular disease. In addition, novel approaches are presented for the treatment of metabolic disease, disturbances of calcium homeostasis and migraine.

Original languageEnglish
Pages (from-to)4005-4008
Number of pages4
JournalBritish Journal of Pharmacology
Volume175
Issue number21
DOIs
Publication statusPublished - 1 Nov 2018

Cite this

@article{37390d54f16049509439fd29a43b9205,
title = "Molecular pharmacology of GPCRs",
abstract = "This themed section of the British Journal of Pharmacology stems from the ninth in the series of MPGPCR meetings, held as a joint initiative with the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists in Melbourne, Australia, from 28 to 30 November 2016. The articles provide insights into how GPCR environment can influence function, the identification of new drug targets based on allostery, biased agonism and oligomerization and the importance of taking into account sexual dimorphism in developing animal models for the evaluation of potential treatments for cardiovascular disease. In addition, novel approaches are presented for the treatment of metabolic disease, disturbances of calcium homeostasis and migraine.",
author = "Langmead, {Christopher J.} and Summers, {Roger J.}",
year = "2018",
month = "11",
day = "1",
doi = "10.1111/bph.14474",
language = "English",
volume = "175",
pages = "4005--4008",
journal = "British Journal of Pharmacology",
issn = "1476-5381",
publisher = "Wiley-Blackwell",
number = "21",

}

Molecular pharmacology of GPCRs. / Langmead, Christopher J.; Summers, Roger J.

In: British Journal of Pharmacology, Vol. 175, No. 21, 01.11.2018, p. 4005-4008.

Research output: Contribution to journalEditorialOther

TY - JOUR

T1 - Molecular pharmacology of GPCRs

AU - Langmead, Christopher J.

AU - Summers, Roger J.

PY - 2018/11/1

Y1 - 2018/11/1

N2 - This themed section of the British Journal of Pharmacology stems from the ninth in the series of MPGPCR meetings, held as a joint initiative with the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists in Melbourne, Australia, from 28 to 30 November 2016. The articles provide insights into how GPCR environment can influence function, the identification of new drug targets based on allostery, biased agonism and oligomerization and the importance of taking into account sexual dimorphism in developing animal models for the evaluation of potential treatments for cardiovascular disease. In addition, novel approaches are presented for the treatment of metabolic disease, disturbances of calcium homeostasis and migraine.

AB - This themed section of the British Journal of Pharmacology stems from the ninth in the series of MPGPCR meetings, held as a joint initiative with the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists in Melbourne, Australia, from 28 to 30 November 2016. The articles provide insights into how GPCR environment can influence function, the identification of new drug targets based on allostery, biased agonism and oligomerization and the importance of taking into account sexual dimorphism in developing animal models for the evaluation of potential treatments for cardiovascular disease. In addition, novel approaches are presented for the treatment of metabolic disease, disturbances of calcium homeostasis and migraine.

UR - http://www.scopus.com/inward/record.url?scp=85054775391&partnerID=8YFLogxK

U2 - 10.1111/bph.14474

DO - 10.1111/bph.14474

M3 - Editorial

VL - 175

SP - 4005

EP - 4008

JO - British Journal of Pharmacology

JF - British Journal of Pharmacology

SN - 1476-5381

IS - 21

ER -